Literature DB >> 23430820

Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in norwegian minors.

Janice Andersen1, Sverre Sandberg, Maalfrid Raaheim, Eva Gjengedal.   

Abstract

OBJECTIVE: The Norwegian Porphyria Centre routinely offers genetic counselling and predictive genetic testing in families diagnosed with porphyria. The aim of this study was to investigate the subjective experiences of adolescents and young adults who were genetically tested for acute intermittent porphyria (AIP) as minors. What were the psychosocial consequences and how were these handled?
METHODS: Qualitative interviews of ten Norwegians aged 16-21 years were performed and analysed based on interpretive description. All participants were initially predictively tested for AIP as minors, but three had subsequently developed manifest disease.
RESULTS: The participants considered early diagnosis and lifestyle moderation advantageous, but finding motivation for precaution was difficult. AIP inflicted few psychosocial challenges and was a small part of the participants' identity, but risk of manifest disease was, nevertheless, a cause for concern for two participants with latent AIP. The participants were content with their present level of knowledge and they felt capable of obtaining relevant information when needed. AIP was experienced as a vague condition, and participants and their relatives attributed a variety of symptoms to the disease. CONCLUSION AND IMPLICATIONS: Being genetically tested as a minor was experienced as useful and entailed relatively few adverse psychosocial consequences, although there was a potential for concern. Appropriate and individually tailored genetic counselling and written consent is subsequently advised. What constitutes a suitable age for testing will differ from individual to individual, but these results suggest that parents in collaboration with their children may be suited to decide what age is appropriate.

Entities:  

Year:  2011        PMID: 23430820      PMCID: PMC3509828          DOI: 10.1007/8904_2011_8

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  25 in total

1.  Adolescent development.

Authors:  L Steinberg; A S Morris
Journal:  Annu Rev Psychol       Date:  2001       Impact factor: 24.137

2.  Assessment of genetic testing and related counseling services: current research and future directions.

Authors:  Catharine Wang; Richard Gonzalez; S D Sofia D Merajver
Journal:  Soc Sci Med       Date:  2004-04       Impact factor: 4.634

3.  Predictive genetic testing: mediators and moderators of anxiety.

Authors:  Susan Michie; David P French; Theresa M Marteau
Journal:  Int J Behav Med       Date:  2002

Review 4.  Risk taking in adolescence: what changes, and why?

Authors:  Laurence Steinberg
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

5.  Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members.

Authors:  Nicolaas P Pronk; Louise H Anderson; A Lauren Crain; Brian C Martinson; Patrick J O'Connor; Nancy E Sherwood; Robin R Whitebird
Journal:  Am J Prev Med       Date:  2004-08       Impact factor: 5.043

6.  Self-rated psychosocial consequences and quality of life in the acute porphyrias.

Authors:  L M Millward; P Kelly; A Deacon; V Senior; T J Peters
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

7.  Women's experience of suffering repeated severe attacks of acute intermittent porphyria.

Authors:  A Wikberg; L Jansson; F Lithner
Journal:  J Adv Nurs       Date:  2000-12       Impact factor: 3.187

8.  [Acute intermittent porphyria is a difficult diagnosis--especially in children].

Authors:  S Sandberg; A Brun; Ø Skadberg; I R Iversen; Y Benestad; O K Danielsen
Journal:  Tidsskr Nor Laegeforen       Date:  2001-10-10

9.  Acute intermittent porphyria in childhood: a population-based study.

Authors:  J Hultdin; A Schmauch; A Wikberg; G Dahlquist; C Andersson
Journal:  Acta Paediatr       Date:  2003-05       Impact factor: 2.299

Review 10.  Human hereditary hepatic porphyrias.

Authors:  Yves Nordmann; Hervé Puy
Journal:  Clin Chim Acta       Date:  2002-11       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.